#USA #PTC Therapeutics #Warren #Investor Relations #Healthcare Conferences

PTC Therapeutics to Participate in Upcoming Investor Conferences

PTC Therapeutics, Inc. (NASDAQ: PTCT), a leading biopharmaceutical company, has exciting news for investors and stakeholders alike. The company has confirmed its participation in several significant investor conferences in the coming month, an opportunity that highlights its ongoing commitment to healthcare innovation and transparency.

Conference Schedule

PTC Therapeutics executives will present at three key conferences:
1. Bank of America Securities Health Care Conference 2026
Date: Tuesday, May 12
Time: 8:40 a.m. PDT / 11:40 a.m. EDT
2. RBC Capital Markets 2026 Global Healthcare Conference
Date: Wednesday, May 20
Time: 10:00 a.m. EDT
3. Goldman Sachs 47th Annual Global Healthcare Conference
Date: Tuesday, June 9
Time: 9:20 a.m. EDT

Each presentation is expected to delve into the latest updates concerning PTC’s advancements in biopharmaceuticals, particularly those aimed at treating rare disorders. Investors can tune in to these live broadcasts via the Events and Presentations page on the PTC Therapeutics website, where the sessions will also be archived for viewing for a month post-event.

About PTC Therapeutics

PTC Therapeutics is known for its robust portfolio of clinically differentiated medicines tailored for both children and adults grappling with rare disorders. The company's mission revolves around the discovery, development, and commercialization of groundbreaking therapies that cater to unmet medical needs. By leveraging its scientific prowess alongside a solid global commercial infrastructure, PTC Therapeutics aims to generate optimal value for its patients and other stakeholders.

With a diversified pipeline of transformative medicines, PTC is positioned to make a substantial impact on the healthcare landscape. Their strategic approach focuses on ensuring that patients have access to best-in-class treatments, underscoring their commitment to improving the quality of life for those affected by rare diseases.

Moving Forward

As the company heads into these conferences, PTC Therapeutics is poised to not only share its latest research developments but also engage with investors and the healthcare community on the broader implications of its work. Investors keen on following the company’s progress can stay updated by visiting PTC’s website or connecting via their social media platforms including LinkedIn, X (formerly Twitter), Instagram, and Facebook.

For inquiries or more information regarding the conferences and overall corporate strategy, stakeholders are encouraged to reach out to:
Investors: Ellen Cavaleri – +1 (615) 618-8228, [email protected]
Media: Jeanine Clemente – +1 (908) 912-9406, [email protected]

Stay tuned, as PTC Therapeutics continues to pave the way in healthcare innovation, promising a brighter future for patients with rare disorders.